menu close
www.maplightrx.com

MapLight Stock

Company Profile:

MapLight is a biopharmaceutical company dedicated to developing targeted treatments for brain disorders. By leveraging proprietary technologies such as optogenetics and STARmap, they aim to identify and modulate specific neural circuits implicated in conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder. This approach seeks to improve patient outcomes by addressing the underlying neural mechanisms of these disorders.

Sign up for SecondMarket® to view the market and buy or sell MapLight Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

MapLight Management Team

  • Chief Discovery Officer

    Anatol Kreitzer

  • Board Member

    Timothy Garnett

  • Board Member

    Robert C. Malenka

  • Chief Administrative Officer, Chief Accounting Officer

    Jonathan Gillis

  • Board Member

    George Pavlov

  • Chief Medical Officer

    Erin Pennock Foff

  • Board Member

    Jim Trenkle

  • CFO

    Vishwas Setia

  • CEO, Board Member, Founder

    Christopher A Kroeger

  • Chief Scientific Officer

    James Lillie

  • Board Member

    Peter Tuxen Bisgaard

Learn More About MapLight Stock

Buy MapLight Stock
01

MapLight stock does not trade on public stock exchanges. MapLight stock is considered a private security and you need to be an accredited investor to trade shares. To invest in MapLight stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell MapLight Stock
02

MapLight Stock does not trade on public stock exchanges. In order to sell MapLight shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

MapLight Stock Price
03

MapLight does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view MapLight share price and other valuable private market data.

Read more about secondary market private company stock prices:

MapLight Stock Ticker Symbol
04

There is no ticker symbol for MapLight stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell MapLight Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell MapLight stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in MapLight Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in MapLight stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

MapLight Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

MapLight IPO
08

MapLight is a private company and has not had an IPO. There is currently no MapLight IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to MapLight IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell MapLight Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Arsenalbio-Logo

ArsenalBio

Develops programmable cell therapies for cancer patients.

Tessera Therapeutics-Logo

Tessera Therapeutics

Genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.

Source: Nasdaq Private Market Tape D®